Partners Investment, a global private markets investment manager, led a $19m series B funding round in Sonde Health, a health technology company, with participation from NEOM Company, KT Corporation, PureTech Health and M Ventures. "Digital biomarkers are becoming a mainstay in healthcare. Today's healthcare companies are realizing how vocal biomarkers can engage people earlier in their health. The data and insights found in voice can power health monitoring and patient stratification so issues can become apparent well before a costly medical event occurs. With voice and any listening device, accessible and effective health monitoring can be made available to the majority of the world," David Liu, Sonde Health CEO.